Federal health regulators remain unconvinced about the benefits of a closely watched experimental drug for the debilitating illness known as Lou Gehrig’s disease, even as they prepare to give its drugmaker a rare second opportunity to make a public case for the treatment.
This article was originally published on MedicalXpress.com
The decision of which college to attend should be made carefully. It is best to seek out information from trustworthy people and avoid college workers. When seeking help, remember that colleges are like sales offices. […]
Almost half of all Canadians regularly take at least one nutritional supplement such as vitamins, minerals, fibre supplements, antacids and fish oils. Many of these individuals are healthy and hoping to improve general well-being or prevent chronic […]
It’s easy to assume that public health measures, such as taxing unhealthy foods, are most successful when they are based on the best available evidence. However, research suggests that evidence-based policy-making doesn’t always dictate public response. Researchers have […]
© 2023 SimplyWell.ca